Signal · Supply Chain & Logistics
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations
What the source reported
Source-reportedMaharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully comply with market recall directions for Reactin Plus Tablets. Further non-compliance was discovered in the unit's distribution and sales system.
- Publication
- The Economic Times - Industry · Trade Publication
- Published
- 28th August 2026
- Original report
- economictimes.indiatimes.com
ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.
What ProcIntel recorded
ProcIntel-derived- Category
- Supply Chain & Logistics
- Geography
- India
- Organisations
- None identified
- Collected
- 28th August 2026 · 14:35
Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Initial Significance Moderate (26.0/100). Strongest contributor: Procurement Impact (21.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (25.5/100, data sufficiency: Insufficient). Strongest contributor: Source Authority (20.0/40 points). Limiting factor: Specificity (0.0/20 points).
- Strongest contributor
- Procurement Impact
- Limiting factor
- Geographic Breadth